Brief: Inflarx Receives Approval To Initiate Phase IIa Clinical Trial

Inflarx NV

27/02/2019 13:52

Feb 27 (Reuters) - Inflarx NV  IFRX.O :
    * INFLARX RECEIVES APPROVAL TO INITIATE PHASE IIA CLINICAL
TRIAL
WITH LEAD CANDIDATE IFX-1 IN PYODERMA GANGRAENOSUM
    * INFLARX NV - STUDY IS ANTICIPATED TO INITIALLY BE
CONDUCTED AT 3
SITES IN CANADA
    * INFLARX NV - TRIAL ENROLMENT IS PLANNED TO START IN Q2 OF
2019.

Source text for Eikon:  ID:nGNXM8kX0 
Further company coverage:  IFRX.O 

 (Reuters.Briefs@thomsonreuters.com)